Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT

Nonmyeloablative regimens are used for allogeneic hematopoietic cell transplantation (HCT) of older or medically unfit patients, but successful outcome is still hindered by graft-versus-host disease (GVHD), especially in the setting of HLA-mismatched HCT. New GVHD prophylaxis strategies are emerging...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Bone Marrow Transplant
Main Authors: van der Velden, Walter J. F. M., Choi, Goda, de Witte, Moniek A., van der Meer, Arnold, de Haan, Anton F. J., Blijlevens, Nicole M. A., Huls, Gerwin, Kuball, Jürgen, van Dorp, Suzanne
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8214052/
https://ncbi.nlm.nih.gov/pubmed/34148060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-021-01369-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados